Cite
Long term follow-up of liver transplantation (OLT) for cholestatic and autoimmune end stage liver diseases
MLA
Blasone L, et al. Long Term Follow-up of Liver Transplantation (OLT) for Cholestatic and Autoimmune End Stage Liver Diseases. Jan. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1299..686b567f76cdb31f1fdf308c826556fd&authtype=sso&custid=ns315887.
APA
Blasone L, Fagiuoli S, Colledan M, Strazzabosco M, Lenzi M, Floreani A, Burra P, Cillo U, Merenda R, Donato MF, Rossi G, Salizzoni M, Franchello A, Rizzetto M, Pinzello G, De Carlis L, Toniutto P, & Andorno E. (2007). Long term follow-up of liver transplantation (OLT) for cholestatic and autoimmune end stage liver diseases.
Chicago
Blasone L, Fagiuoli S, Colledan M, Strazzabosco M, Lenzi M, Floreani A, Burra P, et al. 2007. “Long Term Follow-up of Liver Transplantation (OLT) for Cholestatic and Autoimmune End Stage Liver Diseases,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1299..686b567f76cdb31f1fdf308c826556fd&authtype=sso&custid=ns315887.